104 related articles for article (PubMed ID: 2969985)
1. [The significance of measurement of alpha 2PI-plasmin complex in acute promyelocytic leukemia].
Asakura H; Itoh K; Johkaji Y; Saito M; Uotani C; Kumabashiri I; Matsuda T
Rinsho Ketsueki; 1988 Apr; 29(4):534-8. PubMed ID: 2969985
[No Abstract] [Full Text] [Related]
2. [Evaluation of the assay for alpha 2PI and alpha 2PI-plasmin complex using the one-step sandwich method (EIA)].
Aoki N; Takenaga T; Hasegawa H; Oguma Y; Kobayashi N; Sakata Y; Fujimaki M; Ikematsu S; Kuroso K; Matsuda T
Rinsho Byori; 1987 Nov; 35(11):1275-81. PubMed ID: 2965268
[No Abstract] [Full Text] [Related]
3. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].
Tsuda T; Hayashi H; Tsurumi N; Kuroda M; Takai Y; Kimura I
Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051
[No Abstract] [Full Text] [Related]
4. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; alpha 2 plasmin inhibitor plasmin complex].
Itoh N
Rinsho Byori; 1989 Apr; Spec No 81():202-7. PubMed ID: 2526884
[No Abstract] [Full Text] [Related]
5. Plasmin-alpha 2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Hanano M; Takizawa S; Tatewaki W; Shibata A
Am J Hematol; 1988 Jul; 28(3):162-6. PubMed ID: 2457307
[TBL] [Abstract][Full Text] [Related]
6. [Alpha 2-plasmin inhibitor-plasmin complex].
Yoshikawa Y
Nihon Rinsho; 1999 Sep; 57 Suppl():685-7. PubMed ID: 10543213
[No Abstract] [Full Text] [Related]
7. [Activation of intravascular coagulation and fibrinolysis in cases of APL].
Asakura H; Saito M; Jokaji H; Uotani C; Kumabashiri I; Matsuda T
Rinsho Byori; 1989 Apr; Spec No 81():224-8. PubMed ID: 2526885
[No Abstract] [Full Text] [Related]
8. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
Kawai Y; Watanabe K
Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
[No Abstract] [Full Text] [Related]
9. [Clinical evaluation of alpha 2 plasmin inhibitor and alpha 2 plasmin inhibitor-plasmin complex by enzyme immunoassay method--with special reference to accident surgery].
Fukuda C; Iijima K; Inoue N; Takashima Y; Urabe C; Nakamura K
Rinsho Byori; 1988 Mar; 36(3):346-50. PubMed ID: 2969986
[No Abstract] [Full Text] [Related]
10. [alpha 2-Plasmin inhibitor-plasmin complex (PIC)].
Yoshikawa Y; Sakata Y
Nihon Rinsho; 1995 Mar; 53 Su Pt 2():55-8. PubMed ID: 8753179
[No Abstract] [Full Text] [Related]
11. Alpha-2 plasmin inhibitor-plasmin complex and postoperative blood loss: double-blind study with aprotinin in reoperation for myocardial revascularization.
Minami K; Notohamiprodjo G; Buschler H; Prohaska W; Reichelt W; Körfer R
J Thorac Cardiovasc Surg; 1993 Nov; 106(5):934-6. PubMed ID: 7694000
[No Abstract] [Full Text] [Related]
12. [Analysis of the fibrinolytic response on disseminated intravascular coagulation].
García Frade LJ; García Avello A
Sangre (Barc); 1993 Jun; 38(3):221-4. PubMed ID: 7692611
[No Abstract] [Full Text] [Related]
13. Homogeneous immunoassay for alpha 2 plasmin inhibitor (alpha 2PI) and alpha 2PI-plasmin complex. Application of a sandwich liposome immune lysis assay (LILA) technique.
Hosoda K; Yasuda T
J Immunol Methods; 1989 Jul; 121(1):121-8. PubMed ID: 2526837
[TBL] [Abstract][Full Text] [Related]
14. Changes in plasma levels of protease and fibrinolytic inhibitors induced by treatment in acute myeloid leukemia.
Velasco F; Torres A; Andres P; Martinez F; Gomez P
Thromb Haemost; 1984 Aug; 52(1):81-4. PubMed ID: 6238445
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of fibrinolytic therapy by measuring cross-linked fibrin derivatives and plasmin-alpha 2-plasmin inhibitor complex in plasma.
Takahashi H; Takizawa S; Hanano M; Tatewaki W; Nagasaki Y; Sasagawa Y; Shibata A
Tohoku J Exp Med; 1987 Dec; 153(4):295-302. PubMed ID: 2964745
[TBL] [Abstract][Full Text] [Related]
16. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
Fukuda C; Iijima K; Nakamura K
Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
[TBL] [Abstract][Full Text] [Related]
17. [Hemostatic tests for the diagnosis of thrombosis. Activated coagulation and fibrinolytic factors. Detection of the protease/inhibitor complex].
Iijima K
Rinsho Byori; 1988 Jun; 36(6):623-6. PubMed ID: 2974894
[No Abstract] [Full Text] [Related]
18. Clinical significance of antithrombin III, plasminogen and alpha 2-plasmin inhibitor in perinatal period.
Fuse Y; Fuse K
Asia Oceania J Obstet Gynaecol; 1985 Mar; 11(1):121-5. PubMed ID: 3160323
[No Abstract] [Full Text] [Related]
19. Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukemia.
Kahle LH; Avvisati G; Lamping RJ; Moretti T; Mandelli F; ten Cate JW
Scand J Clin Lab Invest Suppl; 1985; 178():75-80. PubMed ID: 2418490
[TBL] [Abstract][Full Text] [Related]
20. Determination of plasmin-alpha 2-antiplasmin complex in plasma samples by means of a radioimmunoassay.
Wiman B; Jacobsson L; Andersson M; Mellbring G
Scand J Clin Lab Invest; 1983 Feb; 43(1):27-33. PubMed ID: 6194554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
